Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma

By Gemignani M.L.   Schlaerth A.C.   Bogomolniy F.   Barakat R.R.   Lin O.   Soslow R.   Venkatraman E.   Boyd J.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 378-381

Elsevier

Access to resources Recommend Favorite

Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations

By Havrilesky L.J.   Alvarez A.A.   Whitaker R.S.   Marks J.R.   Berchuck A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 491-500

Elsevier

Access to resources Recommend Favorite

Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells

By            

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2469-2476

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo

By          

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 753-759

Spandidos Publications

Access to resources Recommend Favorite

TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88positive human ovarian carcinoma in vitro

By                

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 871-877

Spandidos Publications

Access to resources Recommend Favorite